While host CD103+ cDC1s have not been explicitly evaluated in the context of GvHD, their lymphoid-residing counterpart, CD8α+ cDC1s, have been widely acknowledged as suppressors of GvHD (24–28). Here, ITGAE is linked to graft versus host disease.